Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common stock, $0.10 par value per share
-
Shares outstanding
-
39,496,021
-
Total 13F shares
-
145,821
-
Share change
-
+132,566
-
Total reported value
-
$164,776
-
Price per share
-
$1.13
-
Number of holders
-
11
-
Value change
-
+$149,798
-
Number of buys
-
8
Institutional Holders of Orthofix Medical Inc. - Common stock, $0.10 par value per share (GROM) as of Q4 2023
As of 31 Dec 2023,
Orthofix Medical Inc. - Common stock, $0.10 par value per share (GROM) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
145,821 shares.
The largest 10 holders included
GEODE CAPITAL MANAGEMENT, LLC, Brookstone Capital Management, CITADEL ADVISORS LLC, Weaver Consulting Group, Tower Research Capital LLC (TRC), MORGAN STANLEY, JPMORGAN CHASE & CO, OSAIC HOLDINGS, INC., WELLS FARGO & COMPANY/MN, and Steward Partners Investment Advisory, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.